Validity and Reliability of the Chinese Version of the Diabetes Treatment Burden Questionnaire (DTBQ) Among Patients with Type 2 Diabetes

Yujin Mei; Xue Yang; Yuqing Li; Xiaoyun Zhang; Jiaofeng Gui; Ying Wang; Wenyue Chen; Mingjia Chen; Changjun Liu; Lin Zhang

doi:10.2147/DMSO.S398438

Validity and Reliability of the Chinese Version of the Diabetes Treatment Burden Questionnaire (DTBQ) Among Patients with Type 2 Diabetes

Diabetes Metab Syndr Obes. 2023 Mar 8:16:663-675. doi: 10.2147/DMSO.S398438. eCollection 2023.

Authors

Affiliations

¹ School of Nursing, Wannan Medical College, Wuhu City, Anhui Province, People's Republic of China.
² School of Marxism, Jinzhou Medical University, Jinzhou City, Liaoning Province, People's Republic of China.
³ Department of Internal Medicine Nursing, Wannan Medical College, Wuhu City, Anhui Province, People's Republic of China.

Abstract

Background: In China, diabetes has become a serious healthcare problem that plagues individuals and the government because of its high mortality rate and social burden, with type 2 diabetes mellitus (T2DM) accounting for the vast majority (about 90%) of cases. T2DM patients face a huge medication burden and it is imperative to find appropriate tools to assess the medication burden for patients. This study aimed to translate the original Diabetes Treatment Burden Questionnaire (DTBQ) into Chinese and assessed the reliability and validity of the DTBQ concerning the burden of medication treatment in patients with type 2 diabetes.

Methods: A total of 329 T2DM patients were recruited to participate in the survey. The original version scale was first translated into Chinese using the backward and forward translation procedures. The internal consistency reliability of the scale was measured by the Cronbach alpha coefficient, the test-retest reliability, and the item-total correlation. The validity of the scale was assessed by the content validity index, exploratory factor analysis and confirmatory factor analysis.

Results: The content validity index of the scale was 0.920. Cronbach alpha coefficient for the scale was 0.831. Exploratory factor analysis (EFA) supported a 15-item and 3-factor structure of the translated questionnaire. Confirmatory factor analysis (CFA) showed in the model fitness index, the chi-square degree of freedom was 3.575, the incremental fit index (IFI) was 0.917, the comparative fit index(CFI) was 0.916, the Tucker Lewis Index(TLI) was 0.900, all within acceptable limits. The retest reliability was 0.892, and the corrected item-total correlations for the items ranged from 0.293 to 0.729.

Conclusion: Verification results showed that the Chinese version of the 15-item DTBQ had reliable reliability and validity. Therefore, it can be considered as an appropriate tool to assess the burden of drug treatment for patients with type 2 diabetes in China.

Keywords: T2DM; diabetes treatment burden questionnaire; reliability; validity.

Grants and funding

The research was supported by the Support Program for Outstanding Young Talents from the Universities and Colleges of Anhui Province for Lin Zhang (gxyqZD2021118); The study was supported by the research on the Creation of International Rules for China’s Participation in Global Health Governance and Path Selection (21yjcgjw006); The study was supported by the National Innovation and Entrepreneurship Training Program for College Students (202210368016); The study was supported by the Research Practice of Elderly Nursing (2021shsjkc030).